When to Up Your Mounjaro Dose: What the Titration Process Actually Looks Like

Step 1: completing four weeks at your current dose before any increase

The minimum period at each Mounjaro dose is four weeks. That is not arbitrary, it takes roughly this long for your gastrointestinal system to settle after a dose change, and for your prescriber to get a clear picture of how you are tolerating it. Moving up earlier does not accelerate results; it tends to amplify nausea, vomiting and other GI effects that most people find manageable at a measured pace.

Four weeks is the floor, not the ceiling. If you are still experiencing frequent nausea, diarrhoea or other significant side effects at week four, staying at the current strength for another four weeks is a perfectly reasonable (and common) clinical choice. The NHS tirzepatide medicines page notes that GI side effects are generally most noticeable in the days after starting or increasing a dose, and that they often settle within a couple of weeks. If they have not yet settled by week four, that is useful information for your prescriber.

Practically speaking, many people dose on the same day each week and keep the pen in the fridge door so it is visible, building the injection into a weekly routine makes it easier to notice if something changes around a dose increase.

Step 2: assessing whether the current dose is working well enough

Tolerability is one side of the equation. The other is response. Once you are past the 2.5 mg starter pen, which is designed solely to introduce your body to tirzepatide, your prescriber will want to understand whether the current dose is producing a clinically meaningful effect. For most people, Mounjaro begins to suppress appetite noticeably from 5 mg upwards; the starter dose is specifically calibrated to acclimatise the body, and significant weight-change results tend to emerge at higher maintenance strengths.

NICE's appraisal of tirzepatide (TA1026) references the expectation that treatment at the highest tolerated dose should produce meaningful weight loss, and that if less than 5% body weight has been lost after six months at the highest tolerated dose, continuing is reviewed. This framing is relevant at every step up: your prescriber is weighing whether staying at your current dose is the right call, or whether moving to the next strength is likely to produce better results without unacceptable side effects.

If you are curious about what moving to a specific strength looks like in practice, our page on Mounjaro dose increases covers the clinical factors in more detail.

Step 3: the prescriber's re-review before each increase

At each repeat, a named prescriber reviews your case before approving the next strength. This is not a formality. The review considers your current weight, any side effects you have reported, whether you have been on the previous dose for at least four weeks, and whether there is any new clinical information (a change in medication, a new health condition, or a concern you have raised) that changes the picture.

Evidence checks apply to dose increases: if you are moving up, your prescriber needs to be satisfied that the step is clinically appropriate. This is also the right moment to raise anything you have noticed, a side effect that has not settled, a question about the pace of titration, or whether the schedule is realistic alongside your routine. The review is a conversation, not a rubber stamp.

For context on what private treatment costs across the dose range, our Mounjaro cost page covers what is typically included in a private prescription.

What can delay or pause a dose increase?

Several factors can legitimately slow the titration schedule, and none of them mean treatment is failing. Persistent nausea that has not settled by week four is the most common reason to hold a dose rather than increase it. Diarrhoea or vomiting that is affecting daily life, or any symptom your prescriber considers worth investigating before moving up, will also pause the schedule.

Practical interruptions matter too. A missed pen due to a supply delay, an illness, a surgical procedure (your clinical team should know you are on tirzepatide before any operation), or a period where injections were paused may require your prescriber to reassess the right next step rather than simply proceeding to the next strength. Our guidance on when to go up to 5 mg, including the signs that you are ready to make that step, is one our prescribers hear regularly, and the honest answer is that timings vary person to person, which is exactly why each decision is reviewed individually, as our page on when you go up a dose on Mounjaro explains in more detail.

If you are thinking about starting treatment or want a prescriber to review whether your current dose is right, check your eligibility with our free consultation, a GPhC-registered prescriber will review your case the same day.